Loading ...Yale Epidemiologist Risch Dismayed Over Hydroxychloroquine Media Attacks
Yale epidemiologist Harvey Risch explains the benefits of hydroxychloroquine in early treatment of COVID 19 patients, following U.S. Senate testimony.
“Yale epidemiologist Harvey Risch continues to express dismay over the way hydroxychloroquine has been maligned for political reasons by a pliant media establishment. In his testimony before the U.S. Senate, Risch explains his concerns:”